Naltrexone Neuroimaging in Teens With Eating Disorders — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Naltrexone Neuroimaging in Teens With Eating Disorders — Stella

Recruiting

Back to Eating Disorders trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Children's Mercy Research Institute, Kansas City, Missouri

Key details

Phase

Very early testing

Sponsor

Children's Mercy Hospital Kansas City

Collaborators

University of Kansas Medical Center, National Institute of Mental Health (NIMH)

Enrollment target

~60 participants

Started

September 2022

Primary completion

September 2026

Age range

13 Years – 21 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov